Suppr超能文献

临床实践在预防、诊断和治疗维生素 D 缺乏症:中东欧专家共识声明。

Clinical Practice in the Prevention, Diagnosis and Treatment of Vitamin D Deficiency: A Central and Eastern European Expert Consensus Statement.

机构信息

Department of Biochemistry, Radioimmunology and Experimental Medicine, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.

Department of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, 1085 Budapest, Hungary.

出版信息

Nutrients. 2022 Apr 2;14(7):1483. doi: 10.3390/nu14071483.

Abstract

Vitamin D deficiency has a high worldwide prevalence, but actions to improve this public health problem are challenged by the heterogeneity of nutritional and clinical vitamin D guidelines, with respect to the diagnosis and treatment of vitamin D deficiency. We aimed to address this issue by providing respective recommendations for adults, developed by a European expert panel, using the Delphi method to reach consensus. Increasing the awareness of vitamin D deficiency and efforts to harmonize vitamin D guidelines should be pursued. We argue against a general screening for vitamin D deficiency but suggest 25-hydroxyvitamin D (25(OH)D) testing in certain risk groups. We recommend a vitamin D supplementation dose of 800 to 2000 international units (IU) per day for adults who want to ensure a sufficient vitamin D status. These doses are also recommended for the treatment of vitamin D deficiency, but higher vitamin D doses (e.g., 6000 IU per day) may be used for the first 4 to 12 weeks of treatment if a rapid correction of vitamin D deficiency is clinically indicated before continuing, with a maintenance dose of 800 to 2000 IU per day. Treatment success may be evaluated after at least 6 to 12 weeks in certain risk groups (e.g., patients with malabsorption syndromes) by measurement of serum 25(OH)D, with the aim to target concentrations of 30 to 50 ng/mL (75 to 125 nmol/L).

摘要

维生素 D 缺乏症在全球范围内普遍存在,但由于营养和临床维生素 D 指南在维生素 D 缺乏症的诊断和治疗方面存在异质性,因此采取行动改善这一公共卫生问题面临挑战。我们旨在通过使用 Delphi 方法达成共识,为成年人提供相应的建议来解决这个问题。这些建议是由一个欧洲专家小组制定的。提高对维生素 D 缺乏症的认识并努力协调维生素 D 指南应继续进行。我们反对普遍筛查维生素 D 缺乏症,但建议在某些高危人群中检测 25-羟维生素 D(25(OH)D)。我们建议成年人每天补充 800 至 2000 国际单位(IU)的维生素 D,以确保充足的维生素 D 状态。这些剂量也适用于治疗维生素 D 缺乏症,但如果在继续治疗之前临床需要快速纠正维生素 D 缺乏症,则可能在前 4 至 12 周的治疗中使用更高剂量的维生素 D(例如每天 6000IU),然后每天维持 800 至 2000IU 的剂量。在某些高危人群(例如吸收不良综合征患者)中,至少在 6 至 12 周后通过测量血清 25(OH)D 来评估治疗成功情况,目标浓度为 30 至 50ng/ml(75 至 125nmol/L)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5907/9002638/3e72892cce3c/nutrients-14-01483-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验